Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.
MetadataShow full item record
AbstractThe effect of tamoxifen upon cellular DNA ploidy in carcinoma of the breast was assessed by flow cytometry (FCM), in a prospective group of 77 patients with primary operable disease. Each had a needle biopsy at the outpatient visit for diagnosis and FCM analysis, and definitive surgery was performed a median of 8 days later. Forty received tamoxifen during this period - 40 mg qds loading dose for 24 h, followed by 20 mg daily until the day of operation: 37 patients received no therapy. The DNA histogram from the needle biopsy was compared with that obtained from the resected tumour for each individual. There was little change between the pair of histograms from tumours from the untreated patients. In those who had received tamoxifen the most consistent effect was a marked reduction in the magnitude of the 'tetraploid' peak in tetraploid or near-tetraploid tumours with DNA indices 1.8-2.0. There was little change in diploid or 'other DNA-aneuploid' tumours. In tetraploid tumours (DNA index of 2.0) the percentage of nuclei in the diploid S phase was significantly related to the percentage of nuclei in the diploid G2 + M/tetraploid G1 peak (P less than 0.003, unpaired t test). These data suggest that an effect of tamoxifen can be demonstrated by FCM upon tumours exhibiting a tetraploid or near-tetraploid DNA content. It is possible that tetraploid or near-tetraploid human mammary tumours may be a distinct group of endocrine responsive tumours within the overall group of aneuploid tumours, and that the majority are probably derived from the diploid population rather than being a true aneuploid population.
CitationEffect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast. 1987, 55 (5):561-6 Br. J. Cancer
JournalBritish Journal of Cancer
- DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.
- Authors: Baildam AD, Zaloudik J, Howell A, Barnes DM, Turnbull L, Swindell R, Moore M, Sellwood RA
- Issue date: 1987 May
- The influence of age on the DNA ploidy levels of breast tumours.
- Authors: Taylor IW, Musgrove EA, Friedlander ML, Foo MS, Hedley DW
- Issue date: 1983 May
- Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.
- Authors: Fernando IN, Titley JC, Powles TJ, Dowsett M, Trott PA, Ashley SE, Ford HT, Ormerod MG
- Issue date: 1994 Dec
- Steroid receptor heterogeneity in relation to DNA index in breast cancer: a multiparameter flow cytometric approach on paraffin-embedded tumor samples.
- Authors: Leers MP, Nap M
- Issue date: 2001 Jul-Aug
- Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
- Authors: Grénman SE, Klemi P, Toikkanen S, Irjala K, Laippala P, Vähä-Eskeli K, Mäenpää J, Salmi T
- Issue date: 1994